NCT03326921
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Histiocytic Disorders, Malignant
Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.
260 public trials
43 recruiting studies
Histiocytic Disorders, Malignant trial results
NCT03779854
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
Recruiting
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
NCT07249905
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DLBCL - Diffuse Large B Cell Lymphoma, +28 more
- Locations
-
- Epworth HealthCare Richmond, Victoria, Australia
- Linear Clinical Research Nedlands, Western Australia, Australia
NCT07548697
- Conditions
- B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +14 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT04216524
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Hematologic Diseases, Hematologic Neoplasms, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
- Locations
-
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
NCT07523555
- Conditions
- BPDCN; Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +50 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT06481826
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT06846463
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell Lymphoma, +13 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
NCT06765876
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Bone Marrow Diseases, +23 more
- Locations
-
- Ustav hematologie a krevni transfuze / Institute of Hematology and Blood Transfusion Prague, Czechia